Nanospectra Biosciences Is A Medical Device Company Pioneering A Patient Centric Use Of Nanomedicine For Selective Thermal Ablationaurolasethe Company S Lead Product For The Ablation Of Prostate Cancer Tissueis The First And Only Ultra Focal Tissue Ablation Therapy Designed To Maximize Treatment Efficacy While Minimizing Side Effects Typically Associated With Surgeryradiationand Traditional Focal Therapiesimplementing A Multi Prong Growth Strategynanospectra Is Focusing On Clinical Advancementsexclusive Partnering Agreements And Ongoing Research And Developmentnanospectra S Technology Development Has Been Funded To Date By A Series Of Grantsprivate Equity Investments And Corporate Partnerships
No conferences found for this company.
| Company Name | Nanospectra Biosciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
